The Future of Health Technology Assessment in Pharma
Download a free copy of The Future of Health Technology Assessment in Pharma: A BCC White Paper.
- Cutting-edge knowledge from the Institute for Clinical and Economic Review (ICER), one of the major organizations conducting HTAs.
- Insight into how coronavirus is impacting the HTA process, including pricing considerations for the experimental COVID19 drug Remdesivir.
- Breakdown of metrics used to evaluate pharmaceutical drugs.
Complete our form and we'll send you a free copy.